Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: A systematic review

Drug Safety

Volumn 34, Issue 11, 2011, Pages 1049-1059

  McDowell, Sarah E ^a   Ferner, Robin E ^a,b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ACE inhibitors; Angiotensin receptor antagonists; Antihypertensives; Drug monitoring; Renal function

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BIOCHEMISTRY; EMBASE; FOLLOW UP; HUMAN; HYPERTENSION; MEDLINE; PATIENT MONITORING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIHYPERTENSIVE AGENTS; DRUG MONITORING; HUMANS; HYPERTENSION;

EID: 80053922296     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11593980-000000000-00000     Document Type: Review

References (52)

1. Liamis G, Milionis H, Elisaf M. Blood pressure drug therapy and electrolyte disturbances. Int J Clin Pract 2008; 62: 1572-80
2. Coleman JJ, Ferner RE, Evans SJ. Monitoring for adverse drug reactions. Br J Clin Pharmacol 2006; 61: 371-8
3. Pirmohamed M, Ferner RE. Monitoring drug treatment. BMJ 2003; 327: 1179-81 (Pubitemid 37465199)
4. Gennari FJ. Hypokalemia. N Engl J Med 1998; 339: 451-8 (Pubitemid 28377688)
5. Smellie WS, Forth J, Coleman JJ, et al. Best practice in primary care pathology: review 6. J Clin Pathol 2007; 60: 225-34 (Pubitemid 46447735)
6. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52 (Pubitemid 37553153)
7. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351: 585-92
8. Royal Infirmary of Edinburgh Renal Unit. How to start an ACE inhibitor [online]. Available from URL: http://renux. dmed.ed.ac.uk/edren/Unitbits/ ACEIstart.html [Accessed 2010 Jul 3]
9. Coleman JJ, McDowell SE, Ferner RE. Where does the evidence for guidelines come from? An example of monitoring for the adverse renal effects of ACE inhibitors. Drug Saf 2008; 31: 905-6
10. Sica DA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich) 2006; 8: 67-73
11. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses [online]. Available from URL: www.ohri.ca/programs/clinical-epidemiology/oxford.asp [Accessed 2010 Jan 23]
12. Sauer BC, Kapoor D, Nebeker JR, et al. Serum potassium monitoring in veterans using renin-angiotension-aldo-sterone inhibition. Health Services Research & Development National Meeting; 2006 Feb 16-17; Arlington (VA)
13. Hurley JS, Roberts M, Solberg LI, et al. Laboratory safety monitoring of chronic medications in ambulatory care settings. J Gen Intern Med 2005; 20: 331-3 (Pubitemid 40617601)
14. Raebel MA, Lyons EE, Andrade SE, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005; 20: 1120-6 (Pubitemid 43110262)
15. Palen TE, Raebel M, Lyons E, et al. Evaluation of labora-tory monitoring alerts within a computerized physician order entry system for medication orders. Am J Manag Care 2006; 12: 389-95 (Pubitemid 44061011)
16. Feldstein AC, Smith DH, Perrin N, et al. Improved ther-apeutic monitoring with several interventions: a randomized trial. Arch Intern Med 2006; 166: 1848-54 (Pubitemid 44455167)
17. Matheny ME, Sequist TD, Seger AC, et al. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc 2008; 15: 424-9 (Pubitemid 351888356)
18. Hoch I, Heymann AD, Kurman I, et al. Countrywide com-puter alerts to community physicians improve potassium testing in patients receiving diuretics. J Am Med Inform Assoc 2003; 10: 541-6 (Pubitemid 37377463)
19. Lafata JE, Gunter MJ, Hsu J, et al. Academic detailing to improve laboratory testing among outpatient medication users. Med Care 2007; 45 (10): 966-72
20. Raebel MA, McClure DL, Simon SR, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepi-demiol Drug Saf 2007; 16: 55-64 (Pubitemid 46164976)
21. Gerardin-Marais M, Victorri-Vigneau C, Allain-Veyrac G, et al. Diuretic drug therapy monitoring in the elderly: a cohort study. Eur J Clin Pharmacol 2008; 64: 433-7
22. Simon SR, Andrade SE, Ellis JL, et al. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc 2005; 53: 2165-9 (Pubitemid 43001199)
23. Raebel MA, Ross C, Xu S, et al. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med 2010; 25: 326-33
24. McAlister FA, Tu K, Majumdar SR, et al. Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study. Open Med 2007; 1: E60-7
25. Coleman JJ, McDowell SE, Evans SJW, et al. Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care. Br J Clin Pharmacol 2010; 70: 109-17
26. Besançon JF, Lagarce L, Diquet B, et al. Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination: a population-based analysis. Phar-macoepidemiol Drug Saf 2008; 17: 172-9 (Pubitemid 351308516)
27. Clayton JA, Rodgers S, Blakey J, et al. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol 2006; 61: 87-95 (Pubitemid 43381241)
28. Rhodes KE. Prescription of diuretic drugs and monitoring of long-term use in one general practice. Br J Gen Pract 1992; 42: 68-70
29. Kalra PA, Kumwenda M, MacDowall P, et al. Ques-tionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 1999; 318: 234-7 (Pubitemid 29192031)
30. Raebel MA, McClure DL, Chan KA, et al. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother 2007; 41: 193-200 (Pubitemid 46340049)
31. McDowell SE, Coleman JJ, Evans SJ, et al. Laboratory monitoring and adverse patient outcomes with anti-hypertensive therapy in primary care. Pharmacoepidemiol Drug Saf 2010; 19: 482-9
32. Aronson JK. Diuretics. In: Aronson JK, editor. Meyler's side effects of drugs the international encyclopedia of adverse drug reactions and interactions. 15th ed. Amsterdam: Elsevier; 2006: 1152-69
33. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 1999; 19: 447-52 (Pubitemid 29397071)
34. Bootsma JEM, Warle-van Herwaarden MF, Verbeek ALM, et al. Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands. Drug Saf 2011; 34 (7): 605-14
35. Goldman RE, Soran CS, Hayward GL, et al. Doctors' per-ceptions of laboratory monitoring in office practice. J Eval Clin Pract 2010; 16: 1136-41
36. Williams B, Poulter NR, Brown MJ, et al. British Hy-pertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634-40 (Pubitemid 38340037)
37. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107
38. French Haute Autorite de Sante. Clinical practice guide-lines: management of adults with essential hypertension. 2005 update [online]. Available from URL: http://www. has-sante.fr/portail/upload/docs/application/pdf/Hyperten sion-guidelines.pdf [Accessed 2010 Feb 28]
39. Department of Veterans Affairs/Department of Defense.VA/DoD clinical practice guideline for management of chronic kidney disease in primary care [online]. Available from URL: http://www.healthquality.va.gov/ckd/ckd-v478.pdf [Accessed 2010 Apr 2]
40. National Kidney Foundation. KDOQI clinical practice guide-lines on hypertension and antihypertensive agents in chronic kidney disease [online]. Available from URL: http://www. kidney.org/professionals/KDOQI/guidelines-bp/ index.htm [Accessed 2010 Apr 2]
41. National Institute for Health and Clinical Excellence. NICE clinical guideline 73. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care [online]. Available from URL: http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdf [Accessed 2010 Apr 2]
42. Ferner RE, Coleman J, Pirmohamed M, et al. The quality of information on monitoring for haematological adverse drug reactions. Br J Clin Pharmacol 2005; 60: 448-51 (Pubitemid 41428478)
43. Lo HG, Matheny ME, Seger DL, et al. Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care. J Am Med Inform Assoc 2009; 16: 66-71
44. Avery AJ, Savelyich BS, Sheikh A, et al. Identifying and establishing consensus on the most important safety features of GP computer systems: e-Delphi study. Inform Prim Care 2005; 13: 3-12
45. Isaac T, Weissman JS, Davis RB, et al. Overrides of med-ication alerts in ambulatory care. Arch Intern Med 2009; 169: 305-11
46. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 2006; 13: 5-11 (Pubitemid 41828329)
47. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13: 138-47 (Pubitemid 43332904)
48. van der Sijs H, Aarts J, van Gelder T, et al. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. J Am Med Inform Assoc 2008; 15: 439-48 (Pubitemid 351885159)
49. Fischer SH, Tjia J, Field TS. Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: a systematic review. J Am Med Inform Assoc 2010; 17: 631-6
50. Hayward GL, Parnes AJ, Simon SR. Using health informa-tion technology to improve drug monitoring: a systematic review. Pharmacoepidemiol Drug Saf 2009; 18: 1232-7
51. Poon EG, Gandhi TK, Sequist TD, et al. "I wish I had seen this test result earlier!": dissatisfaction with test result management systems in primary care. Arch Intern Med 2004; 164: 2223-8 (Pubitemid 39452982)
52. Smith DH, Raebel MA, Chan KA, et al. An economic eva-luation of a laboratory monitoring program for renin-angiotensin system agents. Med Decis Making 2011; 31: 315-24